Literature DB >> 33128164

Is routine prenatal screening and testing fundamentally incompatible with a commitment to reproductive choice? Learning from the historical context.

Panagiota Nakou1.   

Abstract

An enduring ethical dispute accompanies prenatal screening and testing (PST) technologies. This ethical debate focuses on notions of reproductive choice. On one side of the dispute are those who have supported PST as a way to empower women's reproductive choice, while on the other side are those who argue that PST, particularly when made a routine part of prenatal care, limits deliberate choice. Empirical research does not resolve this ethical debate with evidence both of women for whom PST enhances their choices but also persistent evidence of recurrent problems between PST and women's autonomous decision-making. While there have been attempts to remove challenges to reproductive choice, it has been argued that these challenges cannot be removed entirely. In this paper I provide a historical review of PST technologies' development and in doing so provide a detailed insight into the root causes of this tension between the opposing sides of this debate. This historical account provides evidence that those who championed the early use of these technologies did so in order to achieve a number of wholly different goals other than women's choice and empowerment. These different aims focus on scientific discovery and eugenic goals and, I argue, are irreconcilable with women's choice and empowerment. It thus may not be surprising that the resulting practice of PST continues to resist compatibility with women's choice and empowerment. Ultimately, by understanding the historical foundations of PST we can more effectively assess how to reconcile women's reproductive autonomy with routine prenatal screening.

Entities:  

Keywords:  Bioethics; Prenatal diagnosis; Prenatal screening; Reproductive autonomy; Reproductive choice; Routinisation

Year:  2020        PMID: 33128164      PMCID: PMC7910369          DOI: 10.1007/s11019-020-09985-w

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  46 in total

1.  Too many choices? Hospital and community staff reflect on the future of prenatal screening.

Authors:  Clare William; Priscilla Alderson; Bobbie Farsides
Journal:  Soc Sci Med       Date:  2002-09       Impact factor: 4.634

Review 2.  Prenatal genetic testing and screening: constructing needs and reinforcing inequities.

Authors:  A Lippman
Journal:  Am J Law Med       Date:  1991

Review 3.  Antenatal genetic testing and the right to remain in ignorance.

Authors:  R Bennett
Journal:  Theor Med Bioeth       Date:  2001-09

4.  Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals.

Authors:  Ananda van den Heuvel; Lyn Chitty; Elizabeth Dormandy; Ainsley Newson; Zuzana Deans; Sophie Attwood; Shelley Haynes; Theresa M Marteau
Journal:  Patient Educ Couns       Date:  2009-06-26

5.  Ethical aspects of non-invasive prenatal diagnosis: medical, market, or regulatory model?

Authors:  G J Annas
Journal:  Early Hum Dev       Date:  1996-12-30       Impact factor: 2.079

6.  Why women say yes to prenatal diagnosis.

Authors:  N Press; C H Browner
Journal:  Soc Sci Med       Date:  1997-10       Impact factor: 4.634

7.  Ethics of routine: a critical analysis of the concept of 'routinisation' in prenatal screening.

Authors:  Robert-Jan H Galjaard; Eline M Bunnik; Adriana Kater-Kuipers; Inez D de Beaufort
Journal:  J Med Ethics       Date:  2018-04-25       Impact factor: 2.903

8.  Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.

Authors:  N J Wald; H Cuckle; J H Brock; R Peto; P E Polani; F P Woodford
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

9.  Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.

Authors:  Alexandra Cernat; Chante De Freitas; Umair Majid; Forum Trivedi; Caroline Higgins; Meredith Vanstone
Journal:  BMC Pregnancy Childbirth       Date:  2019-01-14       Impact factor: 3.007

10.  ACMG statement on noninvasive prenatal screening for fetal aneuploidy.

Authors:  Anthony R Gregg; S J Gross; R G Best; K G Monaghan; K Bajaj; B G Skotko; B H Thompson; M S Watson
Journal:  Genet Med       Date:  2013-04-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.